- Dr. Vanita Arora successfully implanted the AVEIR VR ABBOTT Leadless Pacemaker, marking the first use of this cutting-edge device in Indian cardiac care.
- • The innovative leadless pacemaker was implanted via a transvenous, catheter-based procedure, eliminating the need for surgical incisions and reducing the risk of infection for high-risk patients.
NEW DELHI: Indraprastha Apollo Hospital has marked a significant achievement in Indian cardiology with the first successful implantation of the AVEIR VR ABBOTT Leadless Pacemaker, by Dr. Vanita Arora, clinical lead and an esteemed pioneer in cardiac electrophysiology. This breakthrough, represents a leap forward in pacemaker technology and brings renewed hope to patients requiring cardiac rhythm management, especially those with elevated infection risks.
The patient, a 75-year-old woman with fatigue, energy loss, and presyncope, was diagnosed by Dr. Arora with Sick Sinus Syndrome, a condition where the heart's natural pacemaker deteriorates with age. Due to her history of diabetes, hypertension, and recurrent urinary tract infections, she was at high risk of complications from conventional pacemaker surgery. However, with the AVEIR VR ABBOTT Leadless Pacemaker, Dr. Arora successfully performed a minimally invasive, transvenous procedure, eliminating the need for an incision and device pocket, thus significantly reducing the patient’s infection risk.
The AVEIR VR ABBOTT Leadless Pacemaker boasts several unique features: retrievability for safe removal or adjustment, potential for dual-chamber upgrades, and an impressive 17-year longevity. This revolutionary device is especially beneficial for patients on hemodialysis and those who have previously experienced infections with other pacemaker models, offering them an advanced alternative with fewer complications and restrictions on movement.
Mr. Shivakumar Pattabhiraman, Managing Director, Indraprastha Apollo Hospitals, said, “At Indraprastha Apollo Hospitals, we are proud to lead the way in bringing the latest advancements in cardiac care to India. The successful implantation of the AVEIR VR ABBOTT Leadless Pacemaker marks a new era in patient care, where innovation meets compassion. This pioneering procedure reflects our unwavering commitment to providing cutting-edge technology and world-class healthcare solutions to our patients. By embracing these revolutionary treatments, we are not only improving the quality of life for our patients but also setting new standards in cardiac care across the region."
Dr. Vanita Arora, Clinical Lead, Cardiac Electrophysiologist, Indraprastha Apollo Hospitals, emphasized the importance of this advancement: “The AVEIR VR ABBOTT Leadless Pacemaker is a game-changer in cardiac therapy, offering an innovative, minimally invasive approach that eliminates the need for traditional surgical incisions. This technology not only improves the quality of life for patients but also significantly reduces the risks of infection and complications, especially for those with complex medical conditions. By pioneering the use of this advanced pacemaker, we are not just enhancing the standard of care but also reshaping the future of cardiac rhythm management in India. It is a testament to our commitment to providing patient-centered solutions that prioritize safety, effectiveness, and long-term well-being."
About Indraprastha Apollo Hospitals:
Indraprastha Apollo Hospitals, India's first JCI accredited hospital, is a joint venture between the Government of Delhi and Apollo Hospitals Enterprise Limited. Commissioned in July 1996, it is the third super-specialty tertiary care hospital set up by the Apollo Hospitals Group. Spread over 15 acres, it houses 57 specialties with more than 300 specialists and more than 700 operational beds, 19 operation theatres, 138 ICU beds, round-the-clock pharmacy, NABL accredited laboratories, 24-hour emergency services and an active air ambulance service.
Apollo Hospitals Delhi has the leading programme in kidney and liver transplant in the country. The first successful paediatrics and adult liver transplants in India were performed at Indraprastha Apollo Hospitals. The hospital is at the forefront of medical technology and expertise. It provides a complete range of latest diagnostic, medical and surgical facilities for the care of its patients. The Hospital has introduced the most sophisticated imaging technology to India with the introduction of 64 slice CT and 3 Tesla MRI, Novalis Tx and the integrated PET Suite.
In a groundbreaking advancement, Indraprastha Apollo Hospitals has recently introduced the ZAP-X Gyroscopic Radiosurgery Platform, revolutionizing brain tumor treatment across South Asia. This state-of-the-art technology offers a non-invasive altessrnative to traditional brain surgery, promising improved patient outcomes and comfort. Backed by the experience and expertise of Radiation Oncologists and technical team, Indraprastha Apollo also brings the revolutionary RADIXACT - X9 that combines imaging and treatment delivery to precisely target a wide variety of Cancers. Additionally, the hospital now offers the state-of-the-art Precision Ensite 3D Mapping System for the ablation of complex cardiac arrhythmias, further enhancing its advanced capabilities in treating a diverse range of conditions with precision and care.
Indraprastha Apollo has pioneered the concept of preventive health check programmes and has created a satisfied customer base over decades. The Hospital has been consistently ranked amongst the best 10 hospitals in India by The Week survey for the past few years.
